Literature DB >> 10484968

Olanzapine-induced ketoacidosis with diabetes mellitus.

J P Lindenmayer, R Patel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10484968     DOI： 10.1176/ajp.156.9.1471

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  20 in total

1.  Are African American patients at a higher risk for olanzapine-induced glucose intolerance?

Authors:  J Ananth; S Gunatilake; S Aquino; V Bach; J Costa
Journal:  Psychopharmacology (Berl)       Date:  2001-09       Impact factor: 4.530

Review 2.  Schizotaxia: current status and future directions.

Authors:  Ming T Tsuang; William S Stone; Franziska Gamma; Stephen V Faraone
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 3.  The interface of psychiatric disorders and diabetes mellitus.

Authors:  M K Popkin; E A Colon
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

Review 4.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

5.  Safety of psychotropic medicines: contribution from observational evidence.

Authors:  H Verdoux
Journal:  Epidemiol Psychiatr Sci       Date:  2018-05-30       Impact factor: 6.892

Review 6.  Atypical antipsychotics and diabetic ketoacidosis: a review.

Authors:  Melanie D Guenette; Margaret Hahn; Tony A Cohn; Celine Teo; Gary J Remington
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

Review 7.  Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Authors:  David C Henderson
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 8.  Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Authors:  John W Newcomer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 9.  Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.

Authors:  David C Henderson
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

10.  Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.

Authors:  Cengiz Tuglu; Esin Erdogan; Ercan Abay
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.